Nexocyte
Platform
Biopixlar
Single-cell tools
Publications
Intellectual property
Pipeline
Diabetes
Heart disease
Partnerships
About
News & Events
Leadership & Advisors
Contact
Investors
Press releases
Reports
Financial calendar
Financial documents
Management and board
The share
Annual General Meeting
Contact
EN
EN
SV
contact
EN
SV
Home
/
Platform
/
Publications
/
Differential pharmacologies of mecamylamine enantiomers: Positive allosteric modulation and noncompetitive inhibition
Differential pharmacologies of mecamylamine enantiomers: Positive allosteric modulation and noncompetitive inhibition
Nikolai B. Fedorov, Lisa C. Benson, John Graef, Patrick M. Lippiello, Merouane Bencherif
2009
-
Journal of Pharmacology and Experimental Therapeutics
View publication
Download
Share this publication: